tiprankstipranks
Protagonist Therapeutics (PTGX)
NASDAQ:PTGX
Holding PTGX?
Track your performance easily

Protagonist Therapeutics (PTGX) Financial Statements

616 Followers

Protagonist Therapeutics Financial Overview

Protagonist Therapeutics's market cap is currently ―. The company's EPS TTM is $2.665; its P/E ratio is 15.42; Protagonist Therapeutics is scheduled to report earnings on March 18, 2025, and the estimated EPS forecast is $-0.09. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 4.67M$ 4.17M$ 254.95M$ 60.00M-
Gross Profit$ 4.67M$ 4.17M$ 254.95M$ 60.00M-
EBIT$ -33.61M$ -31.32M$ 206.31M$ 23.05M$ -38.33M
EBITDA$ -32.96M$ -28.81M$ 207.13M$ 23.88M$ -37.50M
Net Income Common Stockholders$ -33.21M$ -30.59M$ 207.34M$ 27.34M$ -34.10M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 468.72M$ 564.04M$ 322.67M$ 341.63M$ 320.73M
Total Assets$ 603.86M$ 614.63M$ 629.28M$ 357.95M$ 330.02M
Total Debt$ 10.90M$ 10.97M$ 462.00K$ 1.14M$ 1.80M
Net Debt$ -457.82M$ -553.07M$ -322.21M$ -340.49M$ -318.92M
Total Liabilities$ 71.94M$ 73.31M$ 68.83M$ 21.27M$ 27.87M
Stockholders Equity$ 531.91M$ 541.31M$ 560.41M$ 336.68M$ 302.15M
Cash Flow-
Free Cash Flow$ -28.64M$ 268.59M$ -27.67M$ 16.94M$ -27.02M
Operating Cash Flow$ -27.86M$ 268.62M$ -27.43M$ 16.96M$ -26.61M
Investing Cash Flow$ -208.71M$ -88.12M$ 6.07M$ -61.29M$ -13.56M
Financing Cash Flow$ 12.05M$ 2.57M$ 7.20M$ 527.00K$ 35.31M
Currency in USD

Protagonist Therapeutics Earnings and Revenue History

Protagonist Therapeutics Debt to Assets

Protagonist Therapeutics Cash Flow

Protagonist Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis